Carol A. Burns

Carol Burns is a serial entrepreneur with extensive experience working in the cardiovascular sector. She has proven success in raising capital, recruiting high performance management teams and top scientific advisors. Ms. Burns has led product development, created worldwide product awareness and has achieved regulatory milestones in a high-quality, timely and capital efficient manner. Ms. Burns recently served as co-founder, President & CEO of Intact Vascular (Wayne, PA) and raised $17M in capital to develop the Tack Endovascular System, a Nitinol implant in a multi-loaded catheter for treatment of peripheral artery disease. Prior to Intact Vascular, she was the first employee of another peripheral vascular company, Embrella Cardiovascular. Ms. Burns served as the Vice President of Product and Business Development which developed a novel embolic protection device for use in Transcatheter Aortic Valve Replacement (TAVR) procedures (acquired by Edwards Lifesciences). Ms. Burns also worked at Animas Corporation (acquired by Johnson and Johnson) as the Sr. Director of International Sales and Marketing. She served as the Managing Director, Europe at Ventrica, Inc. (acquired by Medtronic) and held various management positions at Guidant Corporation working in the cardiac and vascular surgery division where she played a key role in the launch of the first US marketed endovascular abdominal aortic aneurysm device and endoscopic vessel harvesting product for coronary artery bypass surgery. Ms. Burns received her BSN degree from The College of New Jersey, in Ewing, New Jersey.

Carol A. Burns is the Co-Founder, President & CEO at Cagent Vascular, based in United States, North America. With a background in Health Care, Carol A. Burns has a rich history of leadership and innovation.Carol A. Burns studied unknown BSN at The College of New Jersey. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.